retacrit 6,000units0.6ml solution for injection pre-filled syringes
pfizer ltd - epoetin zeta - solution for injection - 10000unit/1ml
retacrit 8,000units0.8ml solution for injection pre-filled syringes
pfizer ltd - epoetin zeta - solution for injection - 10000unit/1ml
retacrit 10,000units1ml solution for injection pre-filled syringes
pfizer ltd - epoetin zeta - solution for injection - 10000unit/1ml
retacrit 40,000units1ml solution for injection pre-filled syringes
pfizer ltd - epoetin zeta - solution for injection - 40000unit/1ml
retacrit 20,000units0.5ml solution for injection pre-filled syringes
pfizer ltd - epoetin zeta - solution for injection - 40000unit/1ml
retacrit 30,000units0.75ml solution for injection pre-filled syringes
pfizer ltd - epoetin zeta - solution for injection - 40000unit/1ml
linezolid 2 mg/ml solution for infusion
mcdermott laboratories ltd., t/a gerard laboratories - linezolid - solution for infusion - 2 milligram(s)/millilitre - other antibacterials; linezolid
regiocit solution for haemofiltration
baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - sodium chloride, sodium citrate - solution for haemofiltration - sodium chloride 5.03 g/l sodium citrate 5.29 g/l sodium 140 mmol/l chloride 86 mmol/l - blood substitutes and perfusion solutions
dobutamine 250mg/50ml solution for infusion vials
hameln pharma ltd - dobutamine hydrochloride - solution for infusion - 5mg/1ml
gadovist 1.0 gadobutrol 1.2094 g/2 ml solution for injection vial
bayer australia ltd - gadobutrol, quantity: 604.72 mg/ml - injection, solution - excipient ingredients: calcobutrol sodium; trometamol; hydrochloric acid; water for injections - this medicinal product is for diagnostic use only. gadovist 1.0 is indicated in adults and children including full-term newborns for: ? contrast enhancement in cranial and spinal magnetic resonance imaging (mri) ? contrast enhancement in whole body mri including head and neck region, thoracic space, breast, abdomen (pancreas, liver and spleen), pelvis (prostate, bladder and uterus), retroperitoneal space (kidney), extremities and musculoskeletal system ? use in first?pass mri studies of cerebral perfusion (see precautions) ? contrast enhancement in magnetic resonance angiography (ce mra) (see clinical trials) ? contrast enhancement in cardiac mri including assessment of rest and pharmacological stress perfusion and delayed enhancement